Patient-centred research provides a better understanding of the impact of bottle modifications on glaucoma patients

Article

Sponsored Feature. Xalatan® is to become available across Europe in a newly designed bottle. So what does that mean and what lies behind that decision?

Related Videos
J. Morgan Micheletti, MD, speaks at the 2024 ASCRS meeting
Dr William Wiley of Cleveland Eye Clinic, Northeast Ohio
Related Content
A patient with a mask has closed eyes. Image credit: ©Ayman Alakhras – stock.adobe.com

Cataract surgery pre-treatment with miLoop: Shorter lensectomy time, less irrigation needed

April 6th 2024
Article

Investigators presented research on the pre-treatment outcomes during the 2024 ASCRS meeting

Site Logo

Novel Therapies in Neovascular AMD and DME: Achieving Superior Anatomic Outcomes with Fewer Injections

June 29th 2023
Podcast
The ZEISS Meditec logo in front of a graph showing a line up. Image credit: ©piter2121 – stock.adobe.com

Carl Zeiss Meditec AG announces completed acquisition of Dutch Ophthalmic Research Center

April 4th 2024
Article

Zeiss has secured regulatory approvals to acquire DORC and will shift focus to integration implementation

Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO

Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO

December 19th 2022
Podcast
Three doors, green, orange and brown, with the numbers 1, 2 and 3 on them. Image created with Canva AI.

Evaluation of an enhanced monofocal intraocular lens

April 3rd 2024
Article

Three IOLs are evaluated in a randomised study

A detective looks through a magnifying glass at an eyeball. Image created with Canva AI.

Hemorrhagic unilateral retinopathy: No proven aetiology for rare condition

April 2nd 2024
Article

Multimodal imaging and a systemic work-up failed to identify any underlying disorder for the hemorrhages

© 2024 MJH Life Sciences

All rights reserved.